Sandra Hernandez’s Post

Curious about dry reagents? We're here to help! One of our subject matter experts recently talked with The Pathologist. Our Sandra Hernandez shares insights, including how this can help with lymphoma and leukemia analysis workflows. Click the link and go to page 32 of the latest issue: https://lnkd.in/e2SeDhiA #InTheNews #FlowCytometry #Reagents #DryReagents

The #BloodCancer landscape continues to evolve through scientific innovations that not only clinically benefit patients, but also strengthen their care and quality of life.     Explore the emerging themes this year to watch for with The Leukemia & Lymphoma Society: https://e.lilly/3P0Rm3F  

On December 6, Alex Morin will speak on a webinar titled, “Clinical Trials: Why They Matter and How to Make Them More Accessible,” with The Leukemia & Lymphoma Society. This webinar is for anyone who cares about making #clinicaltrials more accessible and inclusive—including physicians, researchers, journalists, policymakers, advocates, and patients themselves. Learn more and register here:

💡 #MedPros: Unraveling the link between certain cancers and VTE risk. Lung, kidney, brain, lymphoma, ovarian, pancreatic – share resources with your patients. Empower them in the fight against VTE. https://bit.ly/48RCz2J #WTDay24 #HealthcareResources

𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 9: 𝑳𝑺/𝑩𝑨𝑴𝑳 𝑴𝒂𝒔𝒕𝒆𝒓 𝑻𝒓𝒊𝒂𝒍 Len Rosenberg, Head, Clinical Operations, Beat AML, a division of The Leukemia & Lymphoma Society #day1 #clinicaltrials #clinicaltrialsinnovation #innovation #conference #programme #clinicaltrialsupply #event #ctip #cts

What is Osteoporosis bone marrow defect and how to deal with it? Talk to specialist doctor for cost-effective bone marrow transplant in India, get donor help to reproduce healthy cell and control lymphoma, leukemia. https://lnkd.in/d7XCajmP #bonemarrowcancer #osteoporoticbonemarrow #bonemarrotransplant #bonemarrowtreatment

#AvailableTechnology: Researchers at Emory University have developed a test to detect NF-kB2 breaks to guide treatment for patients with multiple myeloma and lymphomas. Click here to learn more about this technology: https://lnkd.in/dk426AY9 Developed by Leon Bernal-Mizrachi.

New publication 📝 Post hoc analysis results from the SIMPLIFY-1 trial published in Leukemia & Lymphoma provide new insights for #myelofibrosis, see: https://loom.ly/urxylbE

Are you or a loved one affected by #DLBCL? Understanding your treatment options is crucial. Join this upcoming webinar in collaboration with Cancer Support Community and The Leukemia & Lymphoma Society to learn more about the shared decision-making process. https://ow.ly/OQsG50SRsB7 #lymsm

Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment https://lnkd.in/dprhVkWp